Page 208 - Remedial Andrology

779. Waldinger, M.D., et al. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized,
placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin
Psychopharmacol, 1998. 18: 274.
https://pubmed.ncbi.nlm.nih.gov/9690692
780. Waldinger, M.D., et al. SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with
paroxetine and citalopram. J Clin Psychopharmacol, 2001. 21: 556.
https://pubmed.ncbi.nlm.nih.gov/11763001
781. Tanrikut, C., et al. Antidepressant-associated changes in semen parameters. Urology, 2007.
69: 185.e5.
https://pubmed.ncbi.nlm.nih.gov/17270655
782. Tanrikut, C., et al. Adverse effect of paroxetine on sperm. Fertil Steril, 2010. 94: 1021.
https://pubmed.ncbi.nlm.nih.gov/19515367
783. Koyuncu, H., et al. Escitalopram treatment for premature ejaculation has a negative effect on semen
parameters. Int J Impot Res, 2011. 23: 257.
https://pubmed.ncbi.nlm.nih.gov/21776003
784. Koyuncu, H., et al. Deleterious effects of selective serotonin reuptake inhibitor treatment on semen
parameters in patients with lifelong premature ejaculation. Int J Impot Res, 2012. 24: 171.
https://pubmed.ncbi.nlm.nih.gov/22573230
785. Morales, A., et al. A review of the current status of topical treatments for premature ejaculation. BJU
Int, 2007. 100: 493.
https://pubmed.ncbi.nlm.nih.gov/17608824
786. Sachs, B.D., et al. Maintenance of erection of penile glans, but not penile body, after transection of
rat cavernous nerves. J Urol, 1991. 146: 900.
https://pubmed.ncbi.nlm.nih.gov/1875517
787. Wieder, J.A., et al. Anesthetic block of the dorsal penile nerve inhibits vibratory-induced ejaculation
in men with spinal cord injuries. Urology, 2000. 55: 915.
https://pubmed.ncbi.nlm.nih.gov/10840108
788. James, M.M.S., et al. - Topical anaesthetics for premature ejaculation: A systematic review and
meta-analysis. Sexual Health, 2016. 13: 114.
https://pubmed.ncbi.nlm.nih.gov/26599522
789. Pu, C., et al. Topical anesthetic agents for premature ejaculation: a systematic review and meta-
analysis. Urology, 2013. 81: 799.
https://pubmed.ncbi.nlm.nih.gov/23434101
790. Liu, H., et al. Comparative efficacy and safety of drug treatment for premature ejaculation: A
systemic review and Bayesian network meta-analysis. Andrologia, 2020: e13806.
https://pubmed.ncbi.nlm.nih.gov/32892379
791. Atikeler, M.K., et al. Optimum usage of prilocaine-lidocaine cream in premature ejaculation.
Andrologia, 2002. 34: 356.
https://pubmed.ncbi.nlm.nih.gov/12472618
792. Busato, W., et al. Topical anaesthetic use for treating premature ejaculation: a double-blind,
randomized, placebo-controlled study. BJU Int, 2004. 93: 1018.
https://pubmed.ncbi.nlm.nih.gov/15142155
793. Sutton, M., et al. Promescent Has a Cytotoxic Impact on Fresh Human Sperm In Vitro. Urology,
2018. 114: 95.
https://pubmed.ncbi.nlm.nih.gov/29307732
794. Porst, H., et al. Fortacin Spray for the Treatment of Premature Ejaculation. Urologia, 2017. 84: 1.
https://pubmed.ncbi.nlm.nih.gov/30047847
795. Henry, R., et al. TEMPE: Topical Eutectic-Like Mixture for Premature Ejaculation. Expert Opin Drug
Deliv, 2008. 5: 251.
https://pubmed.ncbi.nlm.nih.gov/18248322
796. Dinsmore, W.W., et al. Topical eutectic mixture for premature ejaculation (TEMPE): a novel aerosol-
delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU Int, 2007. 99: 369.
https://pubmed.ncbi.nlm.nih.gov/17129234
797. Dinsmore, W.W., et al. PSD502 improves ejaculatory latency, control and sexual satisfaction when
applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III,
multicentre, double-blind, placebo-controlled study. BJU Int, 2009. 103: 940.
https://pubmed.ncbi.nlm.nih.gov/19245438
798. Carson, C., et al. PSD502 increases ejaculatory latency, control and satisfaction: Results of a phase
III, randomized, doubleblind, placebo-controlled study in the US and Europe. J Sex Med, 2010. [No
abstract available].

SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021 207